Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study

被引：10

作者：

Cartron, Guillaume ^{[1
,2
]}

Letestu, Remi ^{[3
]}

Dartigeas, Caroline ^{[4
]}

Tout, Mira ^{[5
]}

Mahe, Beatrice ^{[6
]}

Gagez, Anne-Laure ^{[1
]}

Ferrant, Emmanuelle ^{[7
]}

Guiu, Boris ^{[8
]}

Villemagne, Bruno ^{[9
]}

Letuan, Phan ^{[10
]}

Aurran, Therese ^{[11
]}

Orsini-Piocelle, Frederique ^{[12
]}

Banos, Anne ^{[13
]}

Feugier, Pierre ^{[14
]}

Leblond, Veronique ^{[15
]}

de Guibert, Sophie ^{[16
]}

Tournilhac, Olivier ^{[17
]}

Dupuis, Jehan ^{[18
]}

Delmer, Alain ^{[19
]}

Rouille, Valerie ^{[1
]}

Ternant, David ^{[5
,20
]}

Lepretre, Stephane ^{[21
,22
,23
]}

机构：

[1] Univ Hosp Montpellier, Dept Clin Hematol, Montpellier, France

[2] Univ Montpellier, CNRS UMR 5235, Montpellier, France

[3] HUPSSD, Hosp Avicenne, AP HP, Dept Biol Hematol, Bobigny, France

[4] Univ Hosp Tours, Dept Clin Hematol, Tours, France

[5] Francois Rabelais Univ, Univ Hosp Tours, CNRS UMR 7292, Tours, France

[6] Univ Hosp Nantes, Dept Clin Hematol, Nantes, France

[7] Univ Hosp Dijon, Dept Clin Hematol, Dijon, France

[8] Univ Hosp Montpellier, Dept Radiol, Montpellier, France

[9] Dept Hosp La Roche Sur Yon, Dept Hematol Oncol, La Roche Sur Yon, France

[10] Univ Inst Clin Res, Lab Biostat, Montpellier, France

[11] Paoli Calmette Ctr, Marseille, France

[12] Hosp Annecy, Dept Clin Hematol, Annecy, France

[13] Hosp Cote Basque, Dept Clin Hematol, Bayonne, France

[14] Univ Hosp Nancy, Dept Clin Hematol, Nancy, France

[15] UPMC Univ Paris 6, Hosp La Pitie Salpetriere, Dept Clin Hematol, GRC11, Paris, France

[16] Univ Hosp Rennes, Dept Clin Hematol, Rennes, France

[17] Univ Hosp Clermont Ferrand, Dept Clin Hematol, Clermont Ferrand, France

[18] Univ Hosp Henri Mondor, Fonct Unit Lymphoid Malignancies, Creteil, France

[19] Univ Hosp Reims, Dept Clin Hematol, Reims, France

[20] Univ Hosp Tours, CNRS, Lab Pharmacol Toxicol, UMR7292, Tours, France

[21] Henri Becquerel Ctr, Inserm U1245, Rouen, France

[22] Henri Becquerel Ctr, Dept Hematol, Rouen, France

[23] Univ Normandy UNIROUEN, Rouen, France

来源：

HAEMATOLOGICA | 2018年 / 103卷 / 08期

关键词：

INTERNATIONAL WORKSHOP; TRIAL; LYMPHOMA; VOLUME; CD20;

D O I：

10.3324/haematol.2017.182352

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E356 / E359

页数：4

共 12 条

[1] Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection [J].

Beers, Stephen A. ;

French, Ruth R. ;

Chan, H. T. Claude ;

Lim, Sean H. ;

Jarrett, Timothy C. ;

Vidal, Regina Mora ;

Wijayaweera, Sahan S. ;

Dixon, Sandra V. ;

Kim, Hyungjin ;

Cox, Kerry L. ;

Kerr, Jonathan P. ;

Johnston, David A. ;

Johnson, Peter W. M. ;

Verbeek, J. Sjef ;

Glennie, Martin J. ;

Cragg, Mark S. .

BLOOD, 2010, 115 (25) :5191-5201

[2] Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial [J].

Boettcher, Sebastian ;

Ritgen, Matthias ;

Fischer, Kirsten ;

Stilgenbauer, Stephan ;

Busch, Raymonde M. ;

Fingerle-Rowson, Guenter ;

Fink, Anna Maria ;

Buehler, Andreas ;

Zenz, Thorsten ;

Wenger, Michael Karl ;

Mendila, Myriam ;

Wendtner, Clemens-Martin ;

Eichhorst, Barbara F. ;

Doehner, Hartmut ;

Hallek, Michael J. ;

Kneba, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) :980-988

[3] Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity [J].

Byrd, JC ;

Murphy, T ;

Howard, RS ;

Lucas, MS ;

Goodrich, A ;

Park, K ;

Pearson, M ;

Waselenko, JK ;

Ling, G ;

Grever, MR ;

Grillo-Lopez, AJ ;

Rosenberg, J ;

Kunkel, L ;

Flinn, IW .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2153-2164

[4] Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].

Cheson, BD ;

Horning, SJ ;

Coiffier, B ;

Shipp, MA ;

Fisher, RI ;

Connors, JM ;

Lister, TA ;

Vose, J ;

Grillo-López, A ;

Hagenbeek, A ;

Cabanillas, F ;

Klippensten, D ;

Hiddemann, W ;

Castellino, R ;

Harris, NL ;

Armitage, JO ;

Carter, W ;

Hoppe, R ;

Canellos, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253

[5] Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20 [J].

Dayde, David ;

Ternant, David ;

Ohresser, Marc ;

Lerondel, Stephanie ;

Pesnel, Sabrina ;

Watier, Herve ;

Le Pape, Alain ;

Bardos, Pierre ;

Paintaud, Gilles ;

Cartron, Guillaume .

BLOOD, 2009, 113 (16) :3765-3772

[6] Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial [J].

Hallek, M. ;

Fischer, K. ;

Fingerle-Rowson, G. ;

Fink, A. M. ;

Busch, R. ;

Mayer, J. ;

Hensel, M. ;

Hopfinger, G. ;

Hess, G. ;

von Gruenhagen, U. ;

Bergmann, M. ;

Catalano, J. ;

Zinzani, P. L. ;

Caligaris-Cappio, F. ;

Seymour, J. F. ;

Berrebi, A. ;

Jaeger, U. ;

Cazin, B. ;

Trneny, M. ;

Westermann, A. ;

Wendtner, C. M. ;

Eichhorst, B. F. ;

Staib, P. ;

Buehler, A. ;

Winkler, D. ;

Zenz, T. ;

Boettcher, S. ;

Ritgen, M. ;

Mendila, M. ;

Kneba, M. ;

Doehner, H. ;

Stilgenbauer, S. .

LANCET, 2010, 376 (9747) :1164-1174

[7] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[8] Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia [J].

Li, Jing ;

Zhi, Jianguo ;

Wenger, Michael ;

Valente, Nancy ;

Dmoszynska, Anna ;

Robak, Tadeusz ;

Mangat, Ranvir ;

Joshi, Amita ;

Visich, Jennifer .

JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (12) :1918-1926

[9] Adrenal gland volume measurement in septic shock and control patients: a pilot study [J].

Nougaret, Stephanie ;

Jung, B. ;

Aufort, S. ;

Chanques, G. ;

Jaber, S. ;

Gallix, B. .

EUROPEAN RADIOLOGY, 2010, 20 (10) :2348-2357

[10] Rituximab dose-escalation trial in chronic lymphocytic leukemia [J].

O'Brien, SM ;

Kantarjian, H ;

Thomas, DA ;

Giles, FJ ;

Freireich, EJ ;

Cortes, J ;

Lerner, S ;

Keating, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2165-2170

← 1 2 →